Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study. Local targets link to admitted publications; unresolved targets remain external evidence.
Racial disparities in diabetes mortality in the 50 most populous US cities
10.1007/s11524-013-9861-4 · 2014 · External reference
Diabetes health disparities: a systematic review of health care interventions
2007 · External reference
Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review
10.2337/diacare.28.9.2280 · 2005 · External reference
Socioeconomic status and risk of diabetes-related mortality in the U.S
10.1177/003335491012500306 · 2010 · External reference
Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review
10.1186/1475-9276-13-43 · 2014 · External reference
Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the translating research into action for diabetes study
10.2337/dc07-1341 · 2008 · External reference
Medicaid expansion and utilization of antihyperglycemic therapies
10.2337/dc20-0735 · 2020 · External reference
9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes - 2021
2021 · External reference
Cost-related barriers to new diabetes medications-a national physician survey
2018 · External reference
Socioeconomic status and cardiovascular outcomes: challenges and interventions
10.1161/circulationaha.117.029652 · 2018 · External reference
Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1•7 million men and women
10.1016/s0140-6736(16)32380-7 · 2017 · External reference
Patient characteristics associated with severe hypoglycemia in a type 2 diabetes cohort in a large, integrated health care system from 2006 to 2015
10.2337/dc17-1834 · 2018 · External reference
Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs
2016 · External reference
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
10.1016/s0197-2456(03)00064-3 · 2003 · External reference
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
10.1056/nejmoa1212914 · 2013 · External reference
The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it
10.1038/oby.2006.84 · 2006 · External reference
A proportional hazards model for the subdistribution of a competing risk
10.1080/01621459.1999.10474144 · 1999 · External reference
Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis
10.2337/dc05-1973 · 2006 · External reference
Clinical benefit of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review
10.1016/j.jacc.2019.11.036 · 2020 · External reference
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
10.1016/j.metabol.2020.154343 · 2020 · External reference
Risk of major adverse cardiovascular events, severe hypoglycemia, and all-cause mortality for widely used antihyperglycemic dual and triple therapies for type 2 diabetes management: a cohort study of all Danish users
10.2337/dc19-2535 · 2020 · External reference
Exhaustion of food budgets at month’s end and hospital admissions for hypoglycemia
2014 · External reference
Racial disparities in diabetes care processes, outcomes, and treatment intensity
10.1097/01.mlr.0000093421.64618.9c · 2003 · External reference
Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse
10.1353/hpu.0.0247 · 2010 · External reference
Unresolved reference
External reference
Correlates of second-line type 2 diabetes medication selection in the USA
10.1136/bmjdrc-2017-000421 · 2017 · External reference
Cardiovascular outcome trials of glucose-lowering medications: an update
10.1007/s00125-018-4801-1 · 2019 · External reference
Assessment of second-generation diabetes medication initiation among medicare enrollees from 2007 to 2015
10.1001/jamanetworkopen.2020.5411 · 2020 · External reference
One-year weight losses in the Look AHEAD study: factors associated with success
10.1038/oby.2008.637 · 2009 · External reference
Use of antihyperglycemic medications in U.S. adults: an analysis of the national health and nutrition examination survey
10.2337/dc19-2424 · 2020 · External reference
